Whats new
Whats new.
Baird - Collab with Merck Provides Downside Support Ahead of Phase 2 HNSCC Data; Maintain OP, $7 PT (Analyst: Joel L. Beatty, MD)
June 6th 2024
For a copy of this research report please contact your Baird advisor
Whats new
June 6th 2024
For a copy of this research report please contact your Baird advisor